News
Gulf Coast Health Care Fraud Strike Force Expanded to Include Eastern District of Texas
- Details
- Written by DOJ DOJ
- Published: 19 November 2020 19 November 2020
Washington, DC - The Department of Justice announced the expansion of the Criminal Division, Fraud Section’s existing Gulf Coast Health Care Fraud Strike Force to include the Eastern District of Texas.
Medicare Advantage Provider to Pay $6.3 Million to Settle False Claims Act Allegations
- Details
- Written by Justice Department Justice Department
- Published: 19 November 2020 19 November 2020
Oakland, California - Kaiser Foundation Health Plan of Washington, formerly known as Group Health Cooperative (GHC), agreed to pay $6,375,000 to resolve allegations that it submitted invalid diagnoses to Medicare for Medicare Advantage beneficiaries and received inflated payments from Medicare as a result, the Justice Department announced today. Kaiser Foundation Health Plan is headquartered in Oakland, California.
This election went to the dogs
- Details
- Written by John Grimaldi John Grimaldi
- Published: 17 November 2020 17 November 2020
Rabbit Hash, Kentucky - Nothing describes the competitive nature of an election as the term “dog eat dog,” but the town of Rabbit Hash, apparently figured out some time ago how to keep things civil when election time comes around.
Library of Congress selects Mayo’s convalescent plasma website for Coronavirus Web Archive
- Details
- Written by YNN YNN
- Published: 19 November 2020 19 November 2020
Washington, DC - The Library of Congress has selected Mayo Clinic's uscovidplasma.org website for the nation's historic Coronavirus Web Archive. Mayo Clinic developed this site as leader of the nation's Expanded Access Program for convalescent plasma to treat COVID-19.
FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs
- Details
- Written by YNN YNN
- Published: 17 November 2020 17 November 2020
Washington, DC - Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg.